Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Zhouchong Wang"'
Autor:
Yinan Shen, Yongpeng Wei, Zhouchong Wang, Yingying Jing, Haiguan He, Jianyong Yuan, Rong Li, Qiudong Zhao, Lixin Wei, Tian Yang, Junhua Lu
Publikováno v:
Cellular Physiology and Biochemistry, Vol 35, Iss 4, Pp 1623-1632 (2015)
Background/Aims: TGF-β plays a key role in the progression of various tumors. The main objective of our study was to investigate whether TGF-β is able to regulate N-nitrosodiethylamine (DEN)-induced hepatocellular carcinoma (HCC) progression in a m
Externí odkaz:
https://doaj.org/article/eab464a206f04a3fabf971882102e3fe
Autor:
Jianyong Yuan, Chun-Feng Shi, Yang Shi, Guang-Shun Yang, Fang Liu, Jun-Hua Lu, Yi-Nan Shen, Jian Cao, Jia-Li Huang, Haiguan He, Yongpeng Wei, Zhouchong Wang, Nan Zhu
Publikováno v:
Molecular Carcinogenesis. 56:751-760
Kruppel-like factor 8 (KLF8) is highly expressed in hepatocellular carcinoma (HCC) and contributes to tumor initiation and progression by promoting HCC cell proliferation and invasion. However, the role of KLF8 in liver cancer stem cells (LCSCs) is n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1131d57f58ad298e98822ec77e31366b
https://doi.org/10.1002/mc.22532
https://doi.org/10.1002/mc.22532
Autor:
Wenqiang Wu, Jin Li, Liang Shen, Li Gang, Junli Xue, Charles Z. Ding, Zhouchong Wang, Chen Shuhui, Chi-Chung Chan, Ye Guo, Dawen Ni, Yuanfeng Xia, Hu Lihong, Yunfei Lin, Xu Xiongbin, Yanan Tang, Shikui Chen
Publikováno v:
Journal of Clinical Oncology. 38:e16126-e16126
e16126 Background: GST-HG161 is an orally bioavailable novel potent and highly selective c-Met inhibitor, which displayed significant antitumor activity in preclinical models as well as very desirable pharmaceutical properties for oral dosing. Precli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e23fd754756f094590b03071c4bf98aa
https://doi.org/10.1200/jco.2020.38.15_suppl.e16126
https://doi.org/10.1200/jco.2020.38.15_suppl.e16126
Autor:
Meng-Chao Wu, Yi-Nan Shen, Jun-Hua Lu, Wan Yee Lau, Zhouchong Wang, Guang-Shun Yang, Kutaiba Alshebeeb, Tian Yang, Feng Shen, Haiguan He, Jianyong Yuan, Jin Zhang
Publikováno v:
Journal of Surgical Oncology. 113:165-174
Background Variceal bleeding can be the first manifestation of patients with newly diagnosed hepatocellular carcinoma (HCC), and effective treatments deserve to be explored for these patients. Methods A prospectively collected database of HCC patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33a9482a5577e0452213bf2f8dfe5c4b
https://doi.org/10.1002/jso.24106
https://doi.org/10.1002/jso.24106
Autor:
Rong Li, Zhouchong Wang, Yi-Nan Shen, Yingying Jing, Haiguan He, Yongpeng Wei, Tian Yang, Jianyong Yuan, Jun-Hua Lu, Qiu-dong Zhao, Lixin Wei
Publikováno v:
Cellular Physiology and Biochemistry, Vol 35, Iss 4, Pp 1623-1632 (2015)
Background/Aims: TGF-β plays a key role in the progression of various tumors. The main objective of our study was to investigate whether TGF-β is able to regulate N-nitrosodiethylamine (DEN)-induced hepatocellular carcinoma (HCC) progression in a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9231f8d3ca5f7016fd58c668fcf5c0e2
https://doi.org/10.1159/000373976
https://doi.org/10.1159/000373976
Autor:
Jun-Hua Lu, Bin Yi, Yongpeng Wei, Qiu Yinghe, Ning Yang, Guang-Shun Yang, Ning-jia Shen, Zhouchong Wang
Publikováno v:
Molecular and Cellular Biochemistry. 381:139-144
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Systemic chemotherapy plays an important role in the treatment of patients with advanced liver cancer. However, chemoresistance to cisplatin is a major limitation of cisplati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b9f00505453d54e97b5b6563c5125f4
https://doi.org/10.1007/s11010-013-1695-6
https://doi.org/10.1007/s11010-013-1695-6
Autor:
Zhouchong Wang, Yongjie Zhang, Wenlong Yu, Ning-jia Shen, Yongpeng Wei, Qiu Yinghe, Kan Tong, Bin Yi
Publikováno v:
Cellular Physiology and Biochemistry, Vol 32, Iss 5, Pp 1331-1341 (2013)
Background/Aims: MicroRNAs (miRNAs) play critical roles during carcinogenesis and cancer progression. Down-regulation of miR-204 has been frequently observed in various cancers. In this study, we investigated the roles and mechanisms of miR-204 in hu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eef3500da8d1fa23e70d4a263dd93299
https://doi.org/10.1159/000354531
https://doi.org/10.1159/000354531
Autor:
Xijun Zhao, Zhipeng Lin, Feng Xiao, Jun Zhao, Jun-Hua Lu, Zhouchong Wang, Jianyong Yuan, Hongxiang Ji
Publikováno v:
Biochemical and biophysical research communications. 483(1)
Increasing evidence indicates that dysregulation of microRNAs (miRNAs) contributes to tumorigenesis. MicroRNA-340 (miR-340) is downregulated in several types of cancer. However, the functional mechanism of miR-340 in hepatocellular carcinoma (HCC) re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ffe2340a7edecd187fa942eebc53af1
https://pubmed.ncbi.nlm.nih.gov/27998770
https://pubmed.ncbi.nlm.nih.gov/27998770
Autor:
Cunling Yan, Wenfeng Lu, Nianyue Wang, Zhouchong Wang, Tian Yang, Shu-Yang Dai, Yijie Zheng, Jun Han, Hao Xing, Jianyong Yuan, Liming Cheng
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. Early diagnosis improves the prognosis. Protein induced by vitamin K antagonist-II (PIVKA-II) is an effective serum biomarker for HCC diagnosis and prognosis. Combi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0339c2370ffece98d6c07978c9c1948
https://pubmed.ncbi.nlm.nih.gov/27739028
https://pubmed.ncbi.nlm.nih.gov/27739028
Autor:
Tian, Yang, Haiguan, He, Jianyong, Yuan, Jin, Zhang, Junhua, Lu, Wan Yee, Lau, Guangshun, Yang, Yinan, Shen, Zhouchong, Wang, Kutaiba, Alshebeeb, Mengchao, Wu, Feng, Shen
Publikováno v:
Journal of surgical oncology. 113(2)
Variceal bleeding can be the first manifestation of patients with newly diagnosed hepatocellular carcinoma (HCC), and effective treatments deserve to be explored for these patients.A prospectively collected database of HCC patients undergoing hepatec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2a8dbc4ca6b5ffd6ee4005e6f0b69545
https://pubmed.ncbi.nlm.nih.gov/26661792
https://pubmed.ncbi.nlm.nih.gov/26661792